Docusign's IAM mix, improving earnings outlook and discounted valuation support its growth case, while liquidity and pricing risks remain in focus.
Docusign shares rose 13.4% in a month as customer expansion, rising IAM adoption and stronger cash flow supported the rally.
DOCU shares jumped 40.2% in six months as AI-powered IAM adoption, revenue growth and rising buybacks strengthened its long-term growth story.
The company maintains a strong competitive moat through extensive enterprise software integrations. Revenue growth has slowed significantly as e-signature market adoption reaches saturation.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DOCU shares slip 2.3% despite a Q2 earnings and revenue beat, as IAM adoption, margin gains and stronger cash flow support results.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DocuSign (DOCU) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Docusign TodayDOCUDocusign$68.41 0.00 (0.00%) As of 09/4/2026 04:00 PM Eastern52-Week Range$40.16▼$86.65P/E Ratio41.71Price Target$67.33Add to WatchlistThe great fear hanging over so many established software firms this year has been that the AI revolution will pass them by, or worse, sweep them aside. Docusign Inc. NASDAQ: DOCU, long the dominant name in electronic signatures, has faced exactly that suspicion, with the bears wondering whether a company built on signing documents online can stay relevant in an age of agentic AI.
The headline numbers for DocuSign (DOCU) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
DocuSign Inc (NASDAQ:DOCU) reported second-quarter revenue and profit that beat Wall Street estimates and raised its full-year revenue guidance, as the company's newer AI-driven contract management products continue to gain share of its overall business. Revenue for the fiscal second quarter came in at $875.7 million, above the $867 million analysts had estimated and up 9% from a year earlier.
Shares of DocuSign (NASDAQ:DOCU) are down 1% to trade at $65.27, pulling back from earlier gains despite the company posting a top- and bottom-line beat for its second-quarter and a raised full-year outlook.